Home/Filings/4/0001493152-25-020753
4//SEC Filing

Farag Kameel D. 4

Accession 0001493152-25-020753

CIK 0001541157other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 5:00 PM ET

Size

7.2 KB

Accession

0001493152-25-020753

Insider Transaction Report

Form 4
Period: 2025-11-01
Farag Kameel D.
Interim CFO
Transactions
  • Award

    American Depositary Shares representing Ordinary Shares

    2025-11-01$0.75/sh+26,619$19,96426,619 total
  • Award

    American Depositary Shares representing Ordinary Shares

    2025-11-01$0.75/sh+32,000$24,00032,000 total
Footnotes (3)
  • [F1]Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer
  • [F2]These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026.
  • [F3]These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on February 15, 2026.

Documents

1 file

Issuer

Akari Therapeutics Plc

CIK 0001541157

Entity typeother

Related Parties

1
  • filerCIK 0002093620

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:00 PM ET
Size
7.2 KB